Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Depression

Free Subscription Articles published in Am J Psychiatry Retrieve available abstracts of 104 articles: HTML format

Single Articles

September 2026
1. BUCIUC AG, Kannarkat JT, Widge AS
   Home-Based Neuromodulation for Depression: Rethinking Access and Oversight.
   Am J Psychiatry. 2026 Sep 23:appiajp20260530. doi: 10.1176/appi.ajp.20260530.
   PubMed    
   
   
   
2. GUIDETTI C, De Giorgi R, Huneke NTM, De Crescenzo F, et al
   Determinants of Nonspecific Response to Treatment in Randomized Controlled Trials of Major Depressive Disorder: A Narrative Review.
   Am J Psychiatry. 2026;183:624-635.
   PubMed     Abstract available
   
   
   
3. YEOM JW, Jeong J, Moon E, Park YM, et al
   Circadian Rhythm Stabilization App to Prevent Mood Episode Recurrence in Patients With Mood Disorders: A Multicenter, Double-Blind, Sham-Controlled, Randomized Clinical Trial.
   Am J Psychiatry. 2026;183:657-667.
   PubMed     Abstract available
   
   
   August 2026
4. CONWAY CR, Sackeim HA, Rush AJ, Bunker M, et al
   The RECOVER Trial of Vagus Nerve Stimulation in Markedly Treatment-Resistant Depression: Critical Findings, Lessons Learned, and Future Directions.
   Am J Psychiatry. 2026 Aug 26:appiajp20251339. doi: 10.1176/appi.ajp.20251339.
   PubMed     Abstract available
   
   
   
5. TAKAMIYA A, Ueda R, Kamiya K, Tajima M, et al
   Hippocampal Dentate Gyrus Plasticity and Its Association With Dimensional Clinical Improvement Across Four Depression Treatment Interventions.
   Am J Psychiatry. 2026 Aug 26:appiajp20251330. doi: 10.1176/appi.ajp.20251330.
   PubMed     Abstract available
   
   
   
6. LI M, Wu Z, Lu X, Zalesky A, et al
   Individualized Connectivity-Guided Versus Conventional Targeting of Accelerated Theta-Burst Stimulation in Depression: A Randomized, Double-Blind, Parallel-Design Trial.
   Am J Psychiatry. 2026 Aug 12:appiajp20251084. doi: 10.1176/appi.ajp.20251084.
   PubMed     Abstract available
   
   
   July 2026
7. VAN DER MEER D, Shadrin AA, Stinson SE, Koch E, et al
   Divergent Patterns of Genetic Overlap Between Severe Mental Disorders and Metabolic Markers.
   Am J Psychiatry. 2026;183:482-493.
   PubMed     Abstract available
   
   
   June 2026
8. KALIN NH
   Treating Severe Depression and Suicidality.
   Am J Psychiatry. 2026;183:367-369.
   PubMed    
   
   
   
9. KELLNER CH, Jelovac A, Braithwaite R
   Relapse Prevention After Successful ECT for Depression: The Role of Lithium and Continuation/Maintenance ECT.
   Am J Psychiatry. 2026;183:370-372.
   PubMed    
   
   
   
10. TUCCIARONE JM, Bandeira ID, Blasey C, Kratter IH, et al
    Low-Dose Buprenorphine Following Ketamine Treatment for Suicidal Ideation in Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Am J Psychiatry. 2026;183:409-419.
    PubMed     Abstract available
    
    
    
11. JELEN LA, O'Daly O, Zelaya FO, Stone JM, et al
    Regional Blood Flow Signatures of Opioidergic Modulation of Ketamine in Major Depressive Disorder: A Randomized Crossover Study.
    Am J Psychiatry. 2026;183:420-430.
    PubMed     Abstract available
    
    
    
12. ROVERS JJE, van Eijndhoven PFP, Abbot C, Argyelan M, et al
    A Global Delphi-Based Expert Consensus on Relapse Prevention Strategies Following Successful Electroconvulsive Therapy for Major Depressive Disorder.
    Am J Psychiatry. 2026;183:401-408.
    PubMed     Abstract available
    
    
    May 2026
13. BLUMBERGER DM, Vila Rodriguez F, McClintock SM, Thorpe KE, et al
    Clinical and Cognitive Outcomes Comparing Right Unilateral Ultrabrief Electroconvulsive Therapy Versus Magnetic Seizure Therapy for Bipolar Depression: The CORRECT-BD Trial.
    Am J Psychiatry. 2026 May 6:appiajp20250955. doi: 10.1176/appi.ajp.20250955.
    PubMed     Abstract available
    
    
    March 2026
14. VALIENGO LDCL, Pinto BS, Luethi M, Afonso Santos L, et al
    Bilateral Theta-Burst Stimulation of Dorsolateral Prefrontal Cortex Regions for Late-Life Depression: A Randomized, Sham-Controlled Clinical Trial.
    Am J Psychiatry. 2026 Mar 11:appiajp20250537. doi: 10.1176/appi.ajp.20250537.
    PubMed     Abstract available
    
    
    January 2026
15. BLOCH MH, Dwyer JB
    Potentially Problematic Research Practices in a Study on Ketamine for Pediatric Depression: Response to Ploderl and Moncrieff.
    Am J Psychiatry. 2026;183:83-85.
    PubMed    
    
    
    
16. PLODERL M, Moncrieff J
    Potentially Problematic Research Practices in a Study on Ketamine for Pediatric Depression.
    Am J Psychiatry. 2026;183:82-83.
    PubMed    
    
    
    
17. KALIN NH
    Externalizing Disorders, Pediatric Anxiety, Autism, and Inflammation-Related Depression.
    Am J Psychiatry. 2026;183:1-3.
    PubMed    
    
    
    
18. MAC GIOLLABHUI N, Madison AA, Lydston M, Lenoel Quang E, et al
    Effect of Anti-Inflammatory Treatment on Depressive Symptom Severity and Anhedonia in Depressed Individuals With Elevated Inflammation: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Am J Psychiatry. 2026;183:70-79.
    PubMed     Abstract available
    
    
    December 2025
19. KALIN NH
    Updates and Advances in the Treatment of Substance Use Disorders, Depression, and Borderline Personality Disorder.
    Am J Psychiatry. 2025;182:1029-1031.
    PubMed    
    
    
    
20. DURGAM S, Earley WR, Kozauer SG, Mo Y, et al
    Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial.
    Am J Psychiatry. 2025;182:1072-1082.
    PubMed     Abstract available
    
    
    
21. BRODSKY BS, Galfalvy H, Mann JJ, Grunebaum MF, et al
    Dialectical Behavior Therapy Versus Serotonin Reuptake Inhibitor Treatment for Suicidal Behavior in Borderline Personality Disorder: A Randomized Controlled Trial.
    Am J Psychiatry. 2025;182:1083-1092.
    PubMed     Abstract available
    
    
    October 2025
22. KALIN NH
    Adolescent Suicidality and Depression, Premenstrual Dysphoric Disorder, and Safety Issues Related to Ketamine and Esketamine Treatment.
    Am J Psychiatry. 2025;182:889-891.
    PubMed    
    
    
    
23. WEI SM, Wakim P, Martinez PE, Nieman LK, et al
    Differential Effects of Ovarian Steroids in Women With and Without Premenstrual Dysphoric Disorder: A Replication and Extension of Findings.
    Am J Psychiatry. 2025;182:922-934.
    PubMed     Abstract available
    
    
    
24. FOUNTOULAKIS KN, Saitis A, Schatzberg AF
    Esketamine Treatment for Depression in Adults: Response to Price et al. and Canuso et al.
    Am J Psychiatry. 2025;182:954-956.
    PubMed    
    
    
    
25. CANUSO CM, Bossie C, Fu DJ, Lane R, et al
    Comment on Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2025;182:951-954.
    PubMed    
    
    
    
26. WHITTLE S, Rakesh D, Simmons JG, Schwartz O, et al
    Prospective Associations Between Structural Brain Development and Onset of Depressive Disorder During Adolescence and Emerging Adulthood.
    Am J Psychiatry. 2025;182:935-944.
    PubMed     Abstract available
    
    
    September 2025
27. LI SW, Kumpf KT, Urrutia J, Krystal JH, et al
    Ketamine for Depression, but at What Cost? A Review of Ketamine's Neurotoxic Effects From Preclinical and Human Studies.
    Am J Psychiatry. 2025 Sep 10:appiajp20250276. doi: 10.1176/appi.ajp.20250276.
    PubMed     Abstract available
    
    
    July 2025
28. AHN Y, Kim J, Jung K, Lee DJ, et al
    Relationship Between Problematic Alcohol Use and Various Psychiatric Disorders: A Genetically Informed Study.
    Am J Psychiatry. 2025;182:671-682.
    PubMed     Abstract available
    
    
    June 2025
29. FONZO GA, Doss MK, Nemeroff CB
    There's More Than One Way to Bring Health Back: Divergent Effects of Psilocybin and Escitalopram Treatment on Emotional Brain Function in Depression.
    Am J Psychiatry. 2025;182:512-515.
    PubMed    
    
    
    
30. KALIN NH
    Depression, Inflammation, and Postpartum Psychosis.
    Am J Psychiatry. 2025;182:501-503.
    PubMed    
    
    
    
31. SAVITZ J, Figueroa-Hall LK, Teague TK, Yeh HW, et al
    Systemic Inflammation and Anhedonic Responses to an Inflammatory Challenge in Adults With Major Depressive Disorder: A Randomized Controlled Trial.
    Am J Psychiatry. 2025;182:560-568.
    PubMed     Abstract available
    
    
    May 2025
32. CLAPP MA, Castro VM, Verhaak P, McCoy TH, et al
    Stratifying Risk for Postpartum Depression at Time of Hospital Discharge.
    Am J Psychiatry. 2025 May 19:appiajp20240381. doi: 10.1176/appi.ajp.20240381.
    PubMed     Abstract available
    
    
    
33. MILLER AH
    Advancing an Inflammatory Subtype of Major Depression.
    Am J Psychiatry. 2025 May 7:appiajp20250289. doi: 10.1176/appi.ajp.20250289.
    PubMed     Abstract available
    
    
    
34. WALL MB, Demetriou L, Giribaldi B, Roseman L, et al
    Reduced Brain Responsiveness to Emotional Stimuli With Escitalopram But Not Psilocybin Therapy for Depression.
    Am J Psychiatry. 2025 May 7:appiajp20230751. doi: 10.1176/appi.ajp.20230751.
    PubMed     Abstract available
    
    
    
35. RUGGIERO KJ, Andrews A, Davidson TM, Gavrilova Y, et al
    Randomized Controlled Trial of "Bounce Back Now," a Mobile App to Reduce Post-Disaster Symptoms of Posttraumatic Stress, Depressed Mood, and Sleep Disturbance.
    Am J Psychiatry. 2025;182:463-472.
    PubMed     Abstract available
    
    
    
36. TANG VM, Aaronson S, Abdelghani M, Baeken C, et al
    Assessment and Management of Concurrent Substance Use in Patients Receiving Repetitive Transcranial Magnetic Stimulation for Depressive, Obsessive-Compulsive, Psychotic, and Trauma-Related Disorders: A Delphi Consensus Study and Guideline.
    Am J Psychiatry. 2025;182:438-451.
    PubMed     Abstract available
    
    
    April 2025
37. CHEN L, Fukuda AM, Jiang S, Leuchter MK, et al
    Treating Depression With Repetitive Transcranial Magnetic Stimulation: A Clinician's Guide.
    Am J Psychiatry. 2025 Apr 30:appiajp20240859. doi: 10.1176/appi.ajp.20240859.
    PubMed     Abstract available
    
    
    March 2025
38. KALIN NH
    New Developments in the Treatment of Depression, OCD, and Schizophrenia.
    Am J Psychiatry. 2025;182:223-226.
    PubMed    
    
    
    
39. MATHEW SJ, Murphy N
    Six Years After Approval of Esketamine Nasal Spray for Serious Depression: Clinical Conundrums and Unanswered Questions.
    Am J Psychiatry. 2025;182:227-230.
    PubMed    
    
    
    
40. BRUNONI AR, Padberg F
    Spaced Transcranial Direct Current Stimulation for Depression: The Road Less Traveled.
    Am J Psychiatry. 2025;182:231-233.
    PubMed    
    
    
    February 2025
41. KING AC, Fischer AM, Cursio JF, Didier NA, et al
    Real-Time Assessment of Alcohol Reward, Stimulation, and Negative Affect in Individuals With and Without Alcohol Use Disorder and Depressive Disorders.
    Am J Psychiatry. 2025;182:187-197.
    PubMed     Abstract available
    
    
    
42. KYPRIOTAKIS G, Cinciripini PM, Green CE, Lawrence D, et al
    Effects of Varenicline, Bupropion, Nicotine Patch, and Placebo on Treating Smoking Among Persons With Current or Past Major Depressive Disorder: Secondary Analysis of a Double-Blind, Randomized, Placebo-Controlled Trial.
    Am J Psychiatry. 2025;182:174-186.
    PubMed     Abstract available
    
    
    January 2025
43. FOUNTOULAKIS KN, Saitis A, Schatzberg AF
    Esketamine Treatment for Depression in Adults: A PRISMA Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2025 Jan 29:appiajp20240515. doi: 10.1176/appi.ajp.20240515.
    PubMed     Abstract available
    
    
    
44. COUTURE M, Desbeaumes Jodoin V, Bousseau E, Sarshoghi A, et al
    Spaced Transcranial Direct Current Stimulation for Major Depression.
    Am J Psychiatry. 2025 Jan 29:appiajp20240083. doi: 10.1176/appi.ajp.20240083.
    PubMed     Abstract available
    
    
    
45. MCINTYRE RS, Kwan ATH, Mansur RB, Oliveira-Maia AJ, et al
    Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research.
    Am J Psychiatry. 2025;182:21-32.
    PubMed     Abstract available
    
    
    
46. AARONSON ST, van der Vaart A, Miller T, LaPratt J, et al
    Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial.
    Am J Psychiatry. 2025;182:104-113.
    PubMed     Abstract available
    
    
    
47. RAMAEKERS JG, Reckweg JT, Mason NL
    Benefits and Challenges of Ultra-Fast, Short-Acting Psychedelics in the Treatment of Depression.
    Am J Psychiatry. 2025;182:33-46.
    PubMed     Abstract available
    
    
    
48. FONZO GA, Wolfgang AS, Barksdale BR, Krystal JH, et al
    Psilocybin: From Psychiatric Pariah to Perceived Panacea.
    Am J Psychiatry. 2025;182:54-78.
    PubMed     Abstract available
    
    
    
49. KIRLIC N, Lennard-Jones M, Atli M, Malievskaia E, et al
    Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.
    Am J Psychiatry. 2025;182:126-132.
    PubMed     Abstract available
    
    
    December 2024
50. WIDOM CS, Courtney K, Do HH
    Pathways to Homelessness: Childhood Maltreatment and Psychiatric Symptoms Increase Risk of Homelessness.
    Am J Psychiatry. 2024;181:1103-1111.
    PubMed     Abstract available
    
    
    
51. GREY DK, Purcell JB, Buford KN, Schuster MA, et al
    Discrimination Exposure, Neural Reactivity to Stress, and Psychological Distress.
    Am J Psychiatry. 2024;181:1112-1126.
    PubMed     Abstract available
    
    
    October 2024
52. GALLUCCI J, Yu JC, Oliver LD, Nakua H, et al
    Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
    Am J Psychiatry. 2024;181:910-919.
    PubMed     Abstract available
    
    
    
53. HWANG M, Brady R
    Neural Circuitry and Therapeutic Targeting of Depressive Symptoms in Schizophrenia Spectrum Disorders.
    Am J Psychiatry. 2024;181:858-860.
    PubMed    
    
    
    September 2024
54. SOARES CN
    Contraception, Intrauterine Systems, and Depression: Can We Spot the Real Perpetrator?
    Am J Psychiatry. 2024;181:789-792.
    PubMed    
    
    
    
55. MARTIN DM, Nikolin S
    "Closing the Loop" With Transcranial Electrical Stimulation for Depression.
    Am J Psychiatry. 2024;181:793-794.
    PubMed    
    
    
    
56. KASTER TS, Blumberger DM
    Positioning rTMS Within a Sequential Treatment Algorithm of Depression.
    Am J Psychiatry. 2024;181:781-783.
    PubMed    
    
    
    
57. KALIN NH
    Depression: Factors Contributing to Risk and Therapeutic Insights.
    Am J Psychiatry. 2024;181:777-780.
    PubMed    
    
    
    
58. DALHUISEN I, van Oostrom I, Spijker J, Wijnen B, et al
    rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches.
    Am J Psychiatry. 2024;181:806-814.
    PubMed     Abstract available
    
    
    
59. SCHWIPPEL T, Pupillo F, Feldman Z, Walker C, et al
    Closed-Loop Transcranial Alternating Current Stimulation for the Treatment of Major Depressive Disorder: An Open-Label Pilot Study.
    Am J Psychiatry. 2024;181:842-845.
    PubMed    
    
    
    
60. HESS EM, Greenstein DK, Hutchinson OL, Zarate CA, et al
    Entactogen Effects of Ketamine: A Reverse-Translational Study.
    Am J Psychiatry. 2024;181:815-823.
    PubMed     Abstract available
    
    
    August 2024
61. SALVATORE JE, Ohlsson H, Sundquist J, Sundquist K, et al
    Peer Social Genetic Effects and the Etiology of Substance Use Disorders, Major Depression, and Anxiety Disorder in a Swedish National Sample.
    Am J Psychiatry. 2024 Aug 7:appiajp20230358. doi: 10.1176/appi.ajp.20230358.
    PubMed     Abstract available
    
    
    July 2024
62. LARSEN SV, Mikkelsen AP, Ozenne B, Munk-Olsen T, et al
    Association Between Intrauterine System Hormone Dosage and Depression Risk.
    Am J Psychiatry. 2024 Jul 10:appiajp20230909. doi: 10.1176/appi.ajp.20230909.
    PubMed     Abstract available
    
    
    
63. POLIMANTI R
    Using Medical Records to Investigate the Genetics of Treatment-Resistant Depression Across Health Care Systems.
    Am J Psychiatry. 2024;181:569-571.
    PubMed    
    
    
    
64. AKIKI TJ, Abdallah CG
    Mapping the Depressed Brain Under Stress Using Multimodal Neuroimaging.
    Am J Psychiatry. 2024;181:578-580.
    PubMed    
    
    
    
65. ROHDE C, Ostergaard SD, Jefsen OH
    A Nationwide Target Trial Emulation Assessing the Risk of Antidepressant-Induced Mania Among Patients With Bipolar Depression.
    Am J Psychiatry. 2024;181:630-638.
    PubMed     Abstract available
    
    
    
66. JONSSON L, Horbeck E, Primerano A, Song J, et al
    Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder.
    Am J Psychiatry. 2024;181:620-629.
    PubMed     Abstract available
    
    
    May 2024
67. KANG J, Castro VM, Ripperger M, Venkatesh S, et al
    Genome-Wide Association Study of Treatment-Resistant Depression: Shared Biology With Metabolic Traits.
    Am J Psychiatry. 2024 May 15:appiajp20230247. doi: 10.1176/appi.ajp.20230247.
    PubMed     Abstract available
    
    
    April 2024
68. BAUM ML, Widge AS, Carpenter LL, McDonald WM, et al
    Pharmacogenomic Clinical Support Tools for the Treatment of Depression.
    Am J Psychiatry. 2024 Apr 30:appiajp20230657. doi: 10.1176/appi.ajp.20230657.
    PubMed     Abstract available
    
    
    
69. IRONSIDE M, Duda JM, Moser AD, Holsen LM, et al
    Association of Lower Rostral Anterior Cingulate GABA+ and Dysregulated Cortisol Stress Response With Altered Functional Connectivity in Young Adults With Lifetime Depression: A Multimodal Imaging Investigation of Trait and State Effects.
    Am J Psychiatry. 2024 Apr 30:appiajp20230382. doi: 10.1176/appi.ajp.20230382.
    PubMed     Abstract available
    
    
    
70. KAVIRAJAN H
    Neglect of Adverse Effects in Treatment Guidelines for Depression.
    Am J Psychiatry. 2024;181:342-345.
    PubMed    
    
    
    March 2024
71. STEFFENS DC
    Late-Life Depression, Antidepressant Treatment, and Cognition: The Short Haul and the Long Haul.
    Am J Psychiatry. 2024;181:183-185.
    PubMed    
    
    
    
72. PHILLIPS ML
    Multimodal Predictors of Treatment Response in Major Depressive Disorder: Advancing Personalized Medicine in Psychiatry.
    Am J Psychiatry. 2024;181:180-182.
    PubMed    
    
    
    
73. POIROT MG, Ruhe HG, Mutsaerts HMM, Maximov II, et al
    Treatment Response Prediction in Major Depressive Disorder Using Multimodal MRI and Clinical Data: Secondary Analysis of a Randomized Clinical Trial.
    Am J Psychiatry. 2024;181:223-233.
    PubMed     Abstract available
    
    
    February 2024
74. AINSWORTH NJ, Marawi T, Maslej MM, Blumberger DM, et al
    Cognitive Outcomes After Antidepressant Pharmacotherapy for Late-Life Depression: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2024 Feb 7:appiajp20230392. doi: 10.1176/appi.ajp.20230392.
    PubMed     Abstract available
    
    
    January 2024
75. KALIN NH
    Improving Clinical Outcomes and Informing New Interventions.
    Am J Psychiatry. 2024;181:1-3.
    PubMed    
    
    
    
76. WALASZEK A
    Optimizing the Treatment of Late-Life Depression.
    Am J Psychiatry. 2024;181:7-10.
    PubMed    
    
    
    
77. RUBINOW DR
    Suicide and the Menstrual Cycle.
    Am J Psychiatry. 2024;181:11-13.
    PubMed    
    
    
    
78. BATAIL JV, Feyder MT, Bentzley BS, Williams NR, et al
    An Avenue for Optimization of Theta Burst Stimulation Protocols? Comments on the FOUR-D Randomized Noninferiority Clinical Trial.
    Am J Psychiatry. 2024;181:68-70.
    PubMed    
    
    
    December 2023
79. KALIN NH
    Adversity and Resilience, Postpartum Depression, Suicide, and Racial/Ethnic Disparities.
    Am J Psychiatry. 2023;180:859-861.
    PubMed    
    
    
    
80. ADAMS JAM, Chandra P, Mehta D
    The First Large GWAS Meta-Analysis for Postpartum Depression.
    Am J Psychiatry. 2023;180:862-864.
    PubMed    
    
    
    
81. STOWE ZN
    Perinatal Mental Health: Advances and Opportunities.
    Am J Psychiatry. 2023;180:874-877.
    PubMed    
    
    
    October 2023
82. GUINTIVANO J, Byrne EM, Kiewa J, Yao S, et al
    Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression.
    Am J Psychiatry. 2023 Oct 18:appiajp20230053. doi: 10.1176/appi.ajp.20230053.
    PubMed     Abstract available
    
    
    
83. ISHTIAK-AHMED K, Musliner KL, Christensen KS, Mortensen EL, et al
    Real-World Evidence on Clinical Outcomes of Commonly Used Antidepressants in Older Adults Initiating Antidepressants for Depression: A Nationwide Cohort Study in Denmark.
    Am J Psychiatry. 2023 Oct 18:appiajp20230356. doi: 10.1176/appi.ajp.20230356.
    PubMed     Abstract available
    
    
    
84. SHACKMAN AJ, Gee DG
    Maternal Perinatal Stress Associated With Offspring Negative Emotionality, But the Underlying Mechanisms Remain Elusive.
    Am J Psychiatry. 2023;180:708-711.
    PubMed    
    
    
    
85. KALIN NH
    Stress, Heritability, and Genetic Factors Influencing Depression, PTSD, and Suicidal Behavior.
    Am J Psychiatry. 2023;180:699-702.
    PubMed    
    
    
    
86. LYNALL ME, McIntosh AM
    The Heterogeneity of Depression.
    Am J Psychiatry. 2023;180:703-704.
    PubMed    
    
    
    
87. NGUYEN TD, Kowalec K, Pasman J, Larsson H, et al
    Genetic Contribution to the Heterogeneity of Major Depressive Disorder: Evidence From a Sibling-Based Design Using Swedish National Registers.
    Am J Psychiatry. 2023;180:714-722.
    PubMed     Abstract available
    
    
    
88. FARHAT LC, Blakey R, Davey Smith G, Fujita A, et al
    Networks of Neurodevelopmental Traits, Socioenvironmental Factors, Emotional Dysregulation in Childhood, and Depressive Symptoms Across Development in Two U.K. Cohorts.
    Am J Psychiatry. 2023;180:755-765.
    PubMed     Abstract available
    
    
    
89. CHATZINAKOS C, Pernia CD, Morrison FG, Iatrou A, et al
    Single-Nucleus Transcriptome Profiling of Dorsolateral Prefrontal Cortex: Mechanistic Roles for Neuronal Gene Expression, Including the 17q21.31 Locus, in PTSD Stress Response.
    Am J Psychiatry. 2023;180:739-754.
    PubMed     Abstract available
    
    
    
90. DOCHERTY AR, Mullins N, Ashley-Koch AE, Qin X, et al
    GWAS Meta-Analysis of Suicide Attempt: Identification of 12 Genome-Wide Significant Loci and Implication of Genetic Risks for Specific Health Factors.
    Am J Psychiatry. 2023;180:723-738.
    PubMed     Abstract available
    
    
    September 2023
91. PINE DS
    Zuranolone Treatment for Depression: Steady Progress in Mechanism-Focused Therapeutics?
    Am J Psychiatry. 2023;180:631-633.
    PubMed    
    
    
    
92. KALIN NH
    Seeking New Solutions Addressing Structural Racism, Childhood Trauma, Suicidal Behaviors Across Sexual Orientations, and Postpartum Depression.
    Am J Psychiatry. 2023;180:625-628.
    PubMed    
    
    
    
93. CLAYTON AH, Lasser R, Parikh SV, Iosifescu DV, et al
    Zuranolone for the Treatment of Adults With Major Depressive Disorder: A Randomized, Placebo-Controlled Phase 3 Trial.
    Am J Psychiatry. 2023;180:676-684.
    PubMed     Abstract available
    
    
    July 2023
94. DELIGIANNIDIS KM, Meltzer-Brody S, Maximos B, Peeper EQ, et al
    Zuranolone for the Treatment of Postpartum Depression.
    Am J Psychiatry. 2023 Jul 26:appiajp20220785. doi: 10.1176/appi.ajp.20220785.
    PubMed     Abstract available
    
    
    
95. JESTER DJ, Kohn JN, Tibirica L, Thomas ML, et al
    Differences in Social Determinants of Health Underlie Racial/Ethnic Disparities in Psychological Health and Well-Being: Study of 11,143 Older Adults.
    Am J Psychiatry. 2023;180:483-494.
    PubMed     Abstract available
    
    
    April 2023
96. BIERNACKA JM
    Do Polygenic Scores Inform Psychiatric Disease Risk After Considering Family History?
    Am J Psychiatry. 2023;180:256-258.
    PubMed    
    
    
    March 2023
97. ELBAU IG, Lynch CJ, Downar J, Vila-Rodriguez F, et al
    Functional Connectivity Mapping for rTMS Target Selection in Depression.
    Am J Psychiatry. 2023;180:230-240.
    PubMed     Abstract available
    
    
    
98. THASE ME
    A New Option for Depressed Patients Who Do Not Respond to Antidepressant Medications.
    Am J Psychiatry. 2023;180:188-189.
    PubMed    
    
    
    
99. KALIN NH
    Insights and Advances Into Treatments for Major Depression.
    Am J Psychiatry. 2023;180:173-176.
    PubMed    
    
    
    
100. JHA MK, Mathew SJ
     Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.
     Am J Psychiatry. 2023;180:190-199.
     PubMed     Abstract available
     
     
     
101. NUNES EV
     Alcohol and the Etiology of Depression.
     Am J Psychiatry. 2023;180:179-181.
     PubMed    
     
     
     
102. SACHS GS, Yeung PP, Rekeda L, Khan A, et al
     Adjunctive Cariprazine for the Treatment of Patients With Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
     Am J Psychiatry. 2023;180:241-251.
     PubMed     Abstract available
     
     
     
103. DUNLOP BW, Cha J, Choi KS, Rajendra JK, et al
     Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy.
     Am J Psychiatry. 2023;180:218-229.
     PubMed     Abstract available
     
     
     
104. HASSERIS S, Albinana C, Vilhjalmsson BJ, Mortensen PB, et al
     Polygenic Risk and Episode Polarity Among Individuals With Bipolar Disorder.
     Am J Psychiatry. 2023;180:200-208.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Depression is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum